Literature DB >> 4177202

Lymphocyte transformation in multiple sclerosis. Inhibition of unstimulated thymidine uptake by a serum factor.

M Knowles, D Hughes, E A Caspary, E J Field.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4177202     DOI: 10.1016/s0140-6736(68)91691-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  18 in total

1.  T and B lymphocytes in multiple sclerosis.

Authors:  R P Lisak; A I Levinson; B Zweiman; N I Abdou
Journal:  Clin Exp Immunol       Date:  1975-10       Impact factor: 4.330

2.  Cold reactive antilymphocyte antibodies in neurological diseases.

Authors:  R P Lisak; F Mercado; B Zweiman
Journal:  J Neurol Neurosurg Psychiatry       Date:  1979-11       Impact factor: 10.154

3.  Lymphocyte transformation by phytohaemagglutinin (PHA) and purified protein derivative (PPD) in primary biliary cirrhosis. Evidence of serum inhibitory factors.

Authors:  R N MacSween; M A Thomas
Journal:  Clin Exp Immunol       Date:  1973-12       Impact factor: 4.330

4.  The effect of plasma upon lymphocyte response in vitro. Demonstration of a humoral inhibitor in patients with sarcoidosis.

Authors:  R J Mangi; J M Dwyer; F S Kantor
Journal:  Clin Exp Immunol       Date:  1974-12       Impact factor: 4.330

5.  [Application and significance of macrophage-electrophoretic-mobility-test (MEM) in neurological diseases (author's transl)].

Authors:  H Meyer-Rienecker; H L Jenssen; H Köhler; J Günther; H J Gundlach
Journal:  Klin Wochenschr       Date:  1974-05-15

6.  Lymphocyte response depressive factor in multiple sclerosis.

Authors:  E J Field; E A Caspary
Journal:  Br Med J       Date:  1971-11-27

7.  Lymphocyte transformation induced in vitro by PHA and PPD in multiple sclerosis.

Authors:  W Cendrowski; K Niedzielska
Journal:  J Neurol Neurosurg Psychiatry       Date:  1970-02       Impact factor: 10.154

8.  Inhibition of PHA-stimulated lymphocyte transformation by plasma from patients with advanced alcoholic cirrhosis.

Authors:  C C Hsu; C M Leevy
Journal:  Clin Exp Immunol       Date:  1971-05       Impact factor: 4.330

9.  Immunological dysfunctions in multiple sclerosis. I. Diminution of 'active' thymus-derived lymphocytes and presence of immunomodulating serum factors.

Authors:  J R Kateley; S J Bazzell
Journal:  Clin Exp Immunol       Date:  1979-02       Impact factor: 4.330

10.  Immunopathologic studies in relapsing polychondritis.

Authors:  J H Herman; M V Dennis
Journal:  J Clin Invest       Date:  1973-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.